David Murray, M.D., Ph.D., explains how Mayo Clinic Laboratories' MASS-FIX Quantitation assay provides next-generation screening for M-proteins, which are associated with multiple myeloma and other diseases. The assay better quantitates the blood proteins, for improved patient care and simpler test ordering.(00:32)Could you provide us with a little bit about yourself and your background? (02:56)Would you elaborate on the role of you and the Mayo Clinic team in advancing insights with the use of mass spectrometry and its initial launch? (05:38)Please share about Quantitative MASS-FIX and its specificity, and which patients should have this testing and when it should be performed. (09:42)Is this a more simplified ordering menu? (15:01)Would you elaborate on how this assay supports the IMWG guidelines? (16:01)Are there any closing remarks you would like to add?

Ver todos los episodios